David Passov, MBA

CEO

David Passov boasts extensive leadership experience in life sciences and clinical research, having successfully led large-scale operations and strategic growth initiatives across global markets. David was born in Estonia and attended Tartu University Medical School before moving to the US in 1993. He earned a biology degree from Boston College and worked in basic science research at Massachusetts General Hospital before entering the biopharmaceutical industry in 1996. Over the years, David has held various roles in clinical operations, project management, business development, and general management at several CROs. He received an MBA from Northeastern University in 2002.

In 2005, David joined ClinStar, where he became CEO in 2019, leading the company through its acquisition by PRA Health Sciences in 2013. He then served as Head of Project Management for the EAPA region and later as Senior VP of Strategic Advisory at PRA/ICON until his retirement in April 2024. David is currently based in the UK and has been living there for the past nine years.